Pictured: Dr Justin Wong and Mr Kurtis Budden (who accepted on behalf of Professor Phil Hansbro) at the Awards Ceremony, March 14, 2019.
Cancer Council NSW has awarded funding to 13 ground-breaking cancer research projects including two to the Centenary Institute – Dr Justin Wong, Head of our Epigenetics and RNA Biology Program for his research ‘Understanding the mechanisms that cause acute myeloid leukaemia’ and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation for his project ‘Could our gut bacteria play a role in lung cancer?’
“We are extremely proud to announce another round of extraordinary projects in 2019. We are confident these projects will provide incredible value to cancer patients and continue to push our progress towards a cancer free future,” said Dr Jane Hobson, Research Grants Manager at Cancer Council NSW.
Funds have been awarded to projects deemed through peer review to be of the highest scientific merit; and through consumer review to be of the most value to the community supporting Cancer Council.
Read the full Cancer Council NSW media release
Research from the Centenary Institute has found that the human enzyme DPP4 does not enable COVID-19 infection in our bodies.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.